. 2024 Dec 27;16(12):1480–1492. doi: 10.4254/wjh.v16.i12.1480

Table 1.

Serum angiopoietin-2 and hypoxia-inducible factor-1α levels in patients with chronic liver diseases

Group	n	Ang-2		HIF-1α
Group	n	mean ± SD (μg/L)	> 35 μg/L, n (%)	mean ± SD (μg/L)	> 100 μg/L, n (%)
HCC	80	42.9 ± 5.1	162 (90.0)	145.6 ± 32.6	163 (90.6)
LC	50	26.2 ± 6.1^a	3 (6.0)^a	79.5 ± 28.4^b	14 (28.0)^b
CH	50	21.8 ± 6.9^b	2 (4.0)^b	60.1 ± 18.8^b	1 (2.0)^b
NC	50	16.9 ± 2.8^b	0 (0.0)^b	23.9 ± 4.2^b	0 (0.0)^b

P < 0.05, compared with the hepatocellular carcinoma group.

P < 0.01, compared with the hepatocellular carcinoma group.

Ang-2: Angiopoietin-2; HIF-lα: Hypoxia-inducible factor-1α; NC: Normal control; HCC: Hepatocellular carcinoma; LC: Liver cirrhosis; CH: Chronic hepatitis.